Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Gefitinib in persistent or recurrent ovarian or primary peritoneal carcinoma
NCT00023699Phase 2Completed
- Sponsor
- GOG Foundation
- Start
- Aug 2001
- Modality
- Small Molecules
- Countries
- 4
01
Overview
A Phase 2 trial of gefitinib in ovarian epithelial cancer, primary peritoneal carcinoma (PPC), sponsored by GOG Foundation. Started Aug 2001; status: completed.
02
Drugs
03
Conditions
ovarian epithelial cancerprimary peritoneal carcinoma (PPC)
Beyond the preview
Go deeper on NCT00023699.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00023699.